Table 2.
ALS Mean (SD) | Control mean (SD) | F | p | Effect size (η2) | Required sample size for a t-test at 0.9 power | |
---|---|---|---|---|---|---|
Non-diffusion measures | ||||||
Motor cortex volume (mm3) | 4.79 × 10−3 (3.08 × 10−4) | 5.09 × 10−3 (4.72 × 10−4) | 2.97 | 0.092 | 0.066 | 78 |
Blood flow (mL/100 g/min) | 50.1 (9.6) | 48.3 (10.2) | 0.77 | 0.385 | 0.018 | 1276 |
Relative iron concentration | 8.7 (7.9) | −12.5 (20.9) | 5.24 | 0.030 ⁎ | 0.168 | 26 |
Primary diffusion/Kurtosis measures | ||||||
Apparent diffusion/Kurtosis coefficient | ||||||
ADC | 8.44 × 10−4 (3.17 × 10−5) | 8.33 × 10−4 (1.58 × 10−5) | 3.89 | 0.055 | 0.085 | 220 |
AKC | 0.953 (0.049) | 0.988 (0.053) | 10.03 | 0.003 ⁎⁎ | 0.193 | 46 |
Fractional anisotropy of diffusion/Kurtosis | ||||||
FA | 0.169 (0.010) | 0.168 (0.017) | 1.52 | 0.225 | 0.035 | 8178 |
FAK | 0.149 (0.012) | 0.140 (0.010) | 3.61 | 0.064 | 0.079 | 66 |
Other diffusion/Kurtosis measures | ||||||
Mean diffusivity/Kurtosis | ||||||
MD | 8.62 × 10−4 (2.06 × 10−4) | 9.60 × 10−4 (2.04 × 10−4) | 0.55 | 0.464 | 0.013 | 160 |
MK | 0.744 (0.039) | 0.775 (0.034) | 12.28 | 0.001 ⁎⁎ | 0.226 | 76 |
Axial diffusivity/Kurtosis | ||||||
AD | 9.93 × 10−4 (3.94 × 10−5) | 9.78 × 10−4 (1.69 × 10−5) | 2.36 | 0.132 | 0.053 | 216 |
AK | 0.674 (0.041) | 0.706 (0.026) | 16.29 | <0.001 ⁎⁎ | 0.280 | 62 |
Radial diffusivity/Kurtosis | ||||||
RD | 7.69 × 10−4 (2.93 × 10−5) | 7.61 × 10−4 (2.01 × 10−5) | 3.88 | 0.056 | 0.085 | 516 |
RK | 0.811 (0.038) | 0.841 (0.040) | 11.29 | 0.002 ⁎⁎ | 0.212 | 90 |
ALS, amyotrophic lateral sclerosis; ADC, apparent diffusion coefficient; AKC, apparent kurtosis coefficient; FA, fractional anisotropy of diffusion; FAK, fractional anisotropy of kurtosis; MD, mean diffusivity; MK, mean kurtosis; AD, axial diffusion; AK, axial kurtosis; RD, radial diffusion; RK, radial kurtosis; SD, standard deviation.
p < 0.05.
p < 0.01.